BENZOTHIAZOLE COMPOUND AND MEDICINE CONTAINING SAME

    公开(公告)号:US20170197956A1

    公开(公告)日:2017-07-13

    申请号:US15326320

    申请日:2015-07-15

    IPC分类号: C07D455/04 C07D417/04

    摘要: It is intended to provide: a compound useful as an amyloid oxidation catalyst which is applicable in vivo and is applicable not only to Aβ peptides but to other amyloids; and a prophylactic or therapeutic drug for an amyloid-related disease, comprising the same. The present invention provides a benzothiazole compound represented by the following formula (1) wherein X represents a halogen atom; R1 represents an optionally substituted hydrocarbon group; R2 represents a hydrogen atom or an optionally substituted hydrocarbon group; R3 and R4 are the same or different and each represent a hydrogen atom, an optionally substituted hydrocarbon group, an alkoxy group, a halogen atom, an amino group, a nitro group, or a cyano group; R2 and R4 optionally together form an alkylene group; and R5 represents an anion.

    CURCUMIN-BORON COMPLEX AND PHARMACEUTICAL CONTAINING SAME

    公开(公告)号:US20190100537A1

    公开(公告)日:2019-04-04

    申请号:US16087017

    申请日:2017-03-21

    摘要: Provided is a compound which is bioapplicable and amyloid-selective, and is useful as an amyloid oxygenation catalyst applicable not only to Aβ peptides but also to other amyloids, and a preventive/therapeutic drug for an amyloid-related disease using the same. A curcumin-boron complex represented by the following formula (1): wherein X1 and X2 are identical or different, and each represent a halogenoalkyl group or a halogen atom; X3 represents a bromine atom, an iodine atom, or a selenium atom; R1 and R2 are identical or different, and each represent a hydrogen atom or an optionally substituted alkyl group; R3 and R4 are identical or different, and each represent a hydrogen atom, a halogen atom, an alkoxy group, or an optionally substituted alkyl group, or R1 and R3 or R2 and R4 are optionally taken together to form an optionally substituted alkylene group or alkenylene group; R5 and R6 are identical or different, and each represent a hydrogen atom or an optionally substituted alkyl group; R7 and R8 are identical or different, and each represent a hydrogen atom, a halogen atom, an alkoxy group, or an optionally substituted alkyl group, or R5 and R7 or R6 and R8 are optionally taken together to form an optionally substituted alkylene group or alkenylene group; and m and n each represent an integer of 1 to 3, or a salt thereof.

    OXIDIZED A BETA PEPTIDE
    3.
    发明申请
    OXIDIZED A BETA PEPTIDE 审中-公开
    氧化一个β肽

    公开(公告)号:US20160137706A1

    公开(公告)日:2016-05-19

    申请号:US14898409

    申请日:2014-06-13

    IPC分类号: C07K14/47 C07K1/113

    摘要: The invention provides an Aβ peptide aggregation inhibitor, an Aβ peptide toxicity reducing agent, and a preventive and/or therapeutic agent for Alzheimer's disease. The oxidized Aβ peptide in which one or more amino acid residues of Aβ peptide have been oxidized (excluding an oxidized Aβ peptide in which only Met has been oxidized).

    摘要翻译: 本发明提供了一种A&bgr; 肽聚集抑制剂,A&bgr; 肽毒性还原剂,以及阿尔茨海默病的预防和/或治疗剂。 氧化的A&bgr 肽,其中A和Bgr的一个或多个氨基酸残基; 肽已被氧化(不包括氧化的A&bgr肽,其中仅Met被氧化)。